ARS Pharmaceuticals, Inc.

SPRY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Aug 22, 2025
4 Aug 22, 2025
4 Aug 21, 2025
144 Aug 21, 2025
144 Aug 21, 2025
144 Aug 19, 2025
10-Q Aug 13, 2025 10-Q
8-K Aug 13, 2025 8-K
SCHEDULE 13D/A Aug 1, 2025
SCHEDULE 13D/A Jul 22, 2025
4 Jul 3, 2025
SCHEDULE 13D/A Jul 2, 2025
4 Jul 1, 2025
144 Jul 1, 2025
4 Jun 27, 2025
4 Jun 27, 2025 4
4 Jun 27, 2025
4 Jun 27, 2025
4 Jun 27, 2025
4 Jun 27, 2025
4 Jun 27, 2025
4 Jun 27, 2025
4 Jun 27, 2025
8-K Jun 26, 2025 8-K
4 Jun 20, 2025
← Newer Page 4 of 22 · 544 filings Older →